Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells

por Mahalingam, D, Natoni, A, Keane, M, Samali, A, Szegezdi, E
Publicado 2010

Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines

por Mahalingam, D, Keane, M, Pirianov, G, Mehmet, H, Samali, A, Szegezdi, E
Publicado 2009

Targeting HSP90 for cancer therapy

por Mahalingam, D, Swords, R, Carew, J S, Nawrocki, S T, Bhalla, K, Giles, F J
Publicado 2009

Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours

por Mahalingam, D, Wilding, G, Denmeade, S, Sarantopoulas, J, Cosgrove, D, Cetnar, J, Azad, N, Bruce, J, Kurman, M, Allgood, V E, Carducci, M
Publicado 2016

Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma

por Mahalingam, D, Espitia, C M, Medina, E C, Esquivel, J A, Kelly, K R, Bearss, D, Choy, G, Taverna, P, Carew, J S, Giles, F J, Nawrocki, S T
Publicado 2011